CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Personalized Miamind Neurostimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05999916
NCT05999916N/ACompleted
CompareCT.gov

A Prospective, Single-Arm, Monocentric Pilot Study to Evaluate the Safety and Feasibility of Transcranial Alternate Current Stimulation With the Miamind Neurostimulator in Healthy Participants

Bottneuro AG·interventional·Posted Aug 21, 2023·Updated Aug 6, 2024

In Brief

A clinical study evaluating Personalized Miamind Neurostimulator for Healthy Participants and Healthy Population. Completed, enrolled 8 participants across 1 site.

Detailed Summary

The present study aims to assess the safety and feasibility of repeated transcranial alternating current stimulation (tACS) by the Miamind Neurostimulator in a cohort of healthy participants. Based on the findings of this investigation, subsequent clinical trials assessing the efficiency of tACS by the Miamind Neurostimulator for treatment of Alzheimer's Disease will be conducted.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Participants, Healthy Population
CountriesSwitzerland
CollaboratorsHemex AG

Timeline

N/ACompletedFinished
202420252026
First PostedAug 21, 2023
Enrollment StartDec 27, 2023
Primary CompletionMar 22, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.9 years ago

Interventions

Personalized Miamind Neurostimulatordevice

60 min. 40 Hz max. 1mA / electrode \& total of max. 2 mA across all electrodes. 30- s ramp-up personalised intervention based on individual modelling of electric field distribution to maximise therapeutic effect in the target region. Three target regions, consecutively stimulated (20min each).